The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Leveraging automation advancements can help improve efficiency in aseptic processing and speed up commercialization of critical drug products. 

Streamlining Aseptic Processes through Automation 

Feliza Mirasol is the science editor for 

Syngene's new production platform offers rapid protein synthesis with lower risk.

New Syngene Platform Aims for Rapid Protein Production

The completed expansion at AGC Biologics'Copenhagen, Denmark, site, doubles the company's single-use bioreactor capacity for mammalian-based services.

AGC Biologics Completes Denmark Expansion to Double Single-Use Bioreactor Capacity

Syntegon will expand its processing and packaging by acquiring the Spanish equipment supplier.

Syntegon Acquires Telstar

USP and FDA publish reports detailing drug shortage numbers and challenges through 2023.

Drug Shortage Reports Emphasize Continuing Problems

The biopharma industry is looking at continuous chromatography for sensitive molecules.

Evaluating the Use of Continuous Chromatography

The final drug product relies on the quality and reliability of the raw materials used in its production.

Diversifying the Supply of Raw Materials 

Lonza’s Joe Garrity and Jerry Jiang discuss the importance of not only automating CGT manufacturing, but also standardizing across processes.

The Need for Automated and Standardized CGT Manufacturing (BIO 2024)

Lonza’s Joe Garrity and Jerry Jiang discuss the latest trends and challenges in commercializing new CGTs. 

Trends and Obstacles in the CGT Field (BIO 2024)

Videos

In this episode of Drug Digest, industry experts discuss the current outsourcing landscape in the post-COVID world and the changes the pandemic has enforced in the demand for outsourced bioprocessing services. 